| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
BAFF, a Splice Isoform of BAFF, Opposes Full-Length BAFF Activity In Vivo in Transgenic Mouse Models1
* Department of Immunology, and Kellogg School of Science and Technology, Doctoral Program in Chemical and Biological Sciences, The Scripps Research Institute, La Jolla, CA 92037; Sir William Dunn School of Pathology, Oxford University, Oxford, United Kingdom; and Biogen-Idec, Cambridge, MA 02142
BAFF is a novel splicing isoform of the regulator B cell-activating factor (BAFF, BLyS), a TNF family protein with powerful immunoregulatory effects. Overexpression of BAFF leads to excessive B cell accumulation, activation, autoantibodies, and lupus-like disease, whereas an absence of BAFF causes peripheral B cell immunodeficiency. Based on the ability of BAFF to multimerize with full-length BAFF and to limit BAFF proteolytic shedding from the cell surface, we previously proposed a role for BAFF in restraining the effects of BAFF and in regulating B lymphocyte homeostasis. To test these ideas we generated mice transgenic for BAFF under the control of human CD68 regulatory elements, which target expression to myeloid and dendritic cells. We also generated in parallel BAFF transgenic mice using the same expression elements. Analysis of the transgenic mice revealed that BAFF and BAFF had opposing effects on B cell survival and marginal zone B cell numbers. BAFF transgenic mice had reduced B cell numbers and T cell-dependent Ab responses, but normal preimmune serum Ig levels. In contrast, BAFF transgenic mice had extraordinarily elevated Ig levels and increases in subsets of B cells. Unexpectedly, both BAFF and BAFF appeared to modulate the numbers of B-1 phenotype B cells.
This article has been cited by other articles:
|
|
 |
|
  Z. Hanna, E. Priceputu, P. Chrobak, C. Hu, V. Dugas, M. Goupil, M. Marquis, L. de Repentigny, and P. Jolicoeur Selective Expression of Human Immunodeficiency Virus Nef in Specific Immune Cell Populations of Transgenic Mice Is Associated with Distinct AIDS-Like Phenotypes J. Virol., October 1, 2009; 83(19): 9743 - 9758. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Le Pottier, B. Bendaoud, Y. Renaudineau, P. Youinou, J.-O. Pers, and C. Daridon New ELISA for B Cell-Activating Factor Clin. Chem., October 1, 2009; 55(10): 1843 - 1851. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Novak, S. L. Slager, Z. S. Fredericksen, A. H. Wang, M. M. Manske, S. Ziesmer, M. Liebow, W. R. Macon, S. R. Dillon, T. E. Witzig, et al. Genetic Variation in B-Cell-Activating Factor Is Associated with an Increased Risk of Developing B-Cell Non-Hodgkin Lymphoma Cancer Res., May 15, 2009; 69(10): 4217 - 4224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Carey, C. S. Moffatt-Blue, L. C. Watson, A. L. Gavin, and A. J. Feeney Repertoire-based selection into the marginal zone compartment during B cell development J. Exp. Med., September 1, 2008; 205(9): 2043 - 2052. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kato, A. Q. Truong-Tran, A. L. Scott, K. Matsumoto, and R. P. Schleimer Airway Epithelial Cells Produce B Cell-Activating Factor of TNF Family by an IFN-beta-Dependent Mechanism J. Immunol., November 15, 2006; 177(10): 7164 - 7172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Miller, J. E. Stadanlick, and M. P. Cancro Space, Selection, and Surveillance: Setting Boundaries with BLyS. J. Immunol., June 1, 2006; 176(11): 6405 - 6410. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
